SEGMENTS (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) Facility	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Segment Reporting Information [Abstract]
Number of plasma collection facilities under development | Facility	10
Number of FDA-licensed plasma collection facilities received approval from Korean Ministry of Food and Drug Safety | Facility	3
Revenues	$ 258,215	$ 154,080	$ 80,943
Cost of product revenue	169,273	118,815	79,770
Income (loss) from operations	21,632	(39,365)	(58,374)
Interest and other expense, net	(23,697)	(19,869)	(13,274)
Loss on extinguishment of debt	(26,174)	(6,670)	0
Net income (loss)	(28,239)	(65,904)	(71,648)
Capital expenditures	4,771	13,911	13,511
Depreciation and amortization expense	8,332	7,113	5,496
Total assets	329,182	348,461	276,253
Corporate [Member]
Segment Reporting Information [Abstract]
Revenues	143	143	143
Cost of product revenue	0	0	0
Income (loss) from operations	(21,845)	(22,336)	(17,024)
Interest and other expense, net	(23,438)	(19,361)	(13,050)
Loss on extinguishment of debt	(26,174)	(6,670)
Net income (loss)	(71,457)	(48,367)	(30,074)
Capital expenditures	0	0	0
Depreciation and amortization expense	0	0	5
Total assets	47,730	73,231	43,180
Operating Segments [Member] | ADMA BioManufacturing [Member]
Segment Reporting Information [Abstract]
Revenues	249,738	144,070	74,936
Cost of product revenue	161,157	108,882	74,126
Income (loss) from operations	47,525	879	(29,294)
Interest and other expense, net	(258)	(505)	(218)
Loss on extinguishment of debt	0	0
Net income (loss)	47,267	374	(29,512)
Capital expenditures	2,952	5,247	4,877
Depreciation and amortization expense	5,156	4,709	4,218
Total assets	246,719	238,159	208,391
Operating Segments [Member] | Plasma Collection Centers [Member]
Segment Reporting Information [Abstract]
Revenues	8,334	9,867	5,864
Cost of product revenue	8,116	9,933	5,644
Income (loss) from operations	(4,048)	(17,908)	(12,056)
Interest and other expense, net	(1)	(3)	(6)
Loss on extinguishment of debt	0	0
Net income (loss)	(4,049)	(17,911)	(12,062)
Capital expenditures	1,819	8,664	8,634
Depreciation and amortization expense	3,176	2,404	1,273
Total assets	$ 34,733	$ 37,071	$ 24,682